...
首页> 外文期刊>APMIS: Acta Pathologica, Microbiologica et Immunologica Scandinavica >Induction of specific cell‐mediated immune responses and protection in BALB/c mice by vaccination with outer membrane vesicles from a Brucella melitensis Brucella melitensis human isolate
【24h】

Induction of specific cell‐mediated immune responses and protection in BALB/c mice by vaccination with outer membrane vesicles from a Brucella melitensis Brucella melitensis human isolate

机译:通过用外膜囊泡从布鲁氏菌红色甲吻素梅利蒂斯人分离株中诱导特异性细胞介导的免疫反应和BALB/C小鼠的保护。

获取原文
获取原文并翻译 | 示例
           

摘要

Brucellosis is a worldwide bacterial zoonosis caused by Brucella spp. No approved vaccine is available for human use against the disease. In this study, outer membrane vesicles ( OMV s) from a Brucella melitensis biovar 1 human isolate obtained in Iran were used to immunize BALB /c mice (n?=?12) by 2 intramuscular injections with a 2‐week interval. Another group of 12 mice was used as non‐vaccinated controls. Two weeks after the last vaccination, six mice of each group were sacrificed, and proliferation and interferon gamma ( IFN γ) production responses of their splenocytes were evaluated following in vitro stimulation with killed Brucella cells. The other mice were challenged with the virulent B.?melitensis isolate. Two weeks later, mice were killed and spleens were cultured to determine the number of the challenge strain. The results showed proliferative response and IFN γ production of splenocytes from vaccinated mice (stimulation index: 2.18?±?0.57, and 1519.35?±?10.70?pg/mL, respectively) were significantly higher than those of control mice (stimulation index: 1.02?±?0.02, and 210.01?±?17.58?pg/mL, respectively). Numbers of the challenge strain in spleens of vaccinated mice were also significantly less than those in the controls with 1.6 units of protection. Our study revealed vaccination with OMV s of the B.?melitensis isolate could induce specific immune responses and protection against infection in the mouse model suggesting their potential application for active immunization against brucellosis.
机译:布鲁氏菌病是由布鲁氏菌属引起的全球细菌动物病。没有批准的疫苗可用于针对该疾病的人类使用。在这项研究中,在伊朗获得的布鲁氏菌Melitensis Biovar 1人分离株的外膜囊泡(OMV s)被2周间隔2周的肌肉注射来免疫BALB /C小鼠(N?=?12)。另一组12只小鼠被用作非接种疫苗的对照。最后一次疫苗接种后两周,处死了每组六只小鼠,并在用杀死的布鲁氏菌细胞体外刺激后评估了其脾细胞的增殖和干扰素伽玛(IFNγ)的产生反应。其他小鼠受到毒性B的挑战。两周后,杀死小鼠并培养脾脏以确定挑战株的数量。结果表明,来自疫苗接种小鼠的脾细胞的增生反应和IFNγ产生(刺激指数:2.18?±?0.57,分别为1519.35?±?10.70?pg/ml)显着高于对照小鼠(刺激指数:1.02:1.02:1.02:1.02 ?±?0.02和210.01?±?17.58?pg/ml)。接种疫苗的小鼠脾脏的挑战株数量也明显少于具有1.6个保护单位的对照组中的挑战株。我们的研究表明,在小鼠模型中,用B.?melitensis分离株进行了疫苗接种,可以诱导特定的免疫反应和防御感染的保护,这表明它们潜在地应用了针对布鲁氏菌病的主动免疫。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号